Page last updated: 2024-10-25

deferiprone and Nephrogenic Systemic Fibrosis

deferiprone has been researched along with Nephrogenic Systemic Fibrosis in 1 studies

Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.

Research Excerpts

ExcerptRelevanceReference
"Nephrogenic systemic fibrosis is associated with gadolinium contrast exposure in patients with reduced kidney function and carries high morbidity and mortality."3.81Evidence Suggesting a Role of Iron in a Mouse Model of Nephrogenic Systemic Fibrosis. ( Bose, C; Hall, KA; Hiatt, KM; Karaduta, O; Megyesi, JK; Shah, SV; Swaminathan, S, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bose, C1
Megyesi, JK1
Shah, SV1
Hiatt, KM1
Hall, KA1
Karaduta, O1
Swaminathan, S1

Other Studies

1 other study available for deferiprone and Nephrogenic Systemic Fibrosis

ArticleYear
Evidence Suggesting a Role of Iron in a Mouse Model of Nephrogenic Systemic Fibrosis.
    PloS one, 2015, Volume: 10, Issue:8

    Topics: Animals; Contrast Media; Deferiprone; Disease Models, Animal; Gadolinium; Gadolinium DTPA; Humans; I

2015